Auteurs
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Naoki Ishiguro »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Naoki Hosogaya < Naoki Ishiguro < Naoki Iwamoto  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000112 (2009) Fumiaki Sugiura [Japon] ; Toshihisa Kojima ; Takeshi Oguchi ; Shirou Urata ; Yukio Yuzawa ; Akihiro Sakakibara ; Hiroki Hayashi ; Norihiro Nishimoto ; Naoki IshiguroA case of peripheral neuropathy and skin ulcer in a patient with rheumatoid arthritis after a single infusion of tocilizumab.
000353 (2011) Takao Koike [Japon] ; Masayoshi Harigai [Japon] ; Shigeko Inokuma [Japon] ; Naoki Ishiguro [Japon] ; Junnosuke Ryu [Japon] ; Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Hisashi Yamanaka [Japon] ; Koichi Fujii [Japon] ; Takunari Yoshinaga [Japon] ; Bruce Freundlich [États-Unis] ; Michio Suzukawa [Japon]Safety and effectiveness responses to etanercept for rheumatoid arthritis in Japan: a sub-analysis of a post-marketing surveillance study focusing on the duration of rheumatoid arthritis
000437 (2011) Takao Koike [Japon] ; Masayoshi Harigai ; Shigeko Inokuma ; Naoki Ishiguro ; Junnosuke Ryu ; Tsutomu Takeuchi ; Syuji Takei ; Yoshiya Tanaka ; Kyoko Ito ; Hisashi YamanakaPostmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients.
000446 (2012) Toshihisa Kojima [Japon] ; Atsushi Kaneko ; Yuji Hirano ; Hisato Ishikawa ; Hiroyuki Miyake ; Takeshi Oguchi ; Hideki Takagi ; Yuichiro Yabe ; Takefumi Kato ; Takayasu Ito ; Kenya Terabe ; Naoki Fukaya ; Yasuhide Kanayama ; Tomone Shioura ; Koji Funahashi ; Masatoshi Hayashi ; Daizo Kato ; Hiroyuki Matsubara ; Takayoshi Fujibayashi ; Masayo Kojima ; Naoki IshiguroStudy protocol of a multicenter registry of patients with rheumatoid arthritis starting biologic therapy in Japan: Tsurumai Biologics Communication Registry (TBCR) study.
000458 (2012) Toshihisa Kojima [Japon] ; Atsushi Kaneko ; Yuji Hirano ; Hisato Ishikawa ; Hiroyuki Miyake ; Hideki Takagi ; Yuichiro Yabe ; Takefumi Kato ; Kenya Terabe ; Naoki Fukaya ; Hiroki Tsuchiya ; Tomone Shioura ; Koji Funahashi ; Masatoshi Hayashi ; Daizo Kato ; Hiroyuki Matsubara ; Naoki IshiguroEarly aggressive intervention with tocilizumab for rheumatoid arthritis increases remission rate defined using a Boolean approach in clinical practice.
000580 (2013) Yuichiro Yabe [Japon] ; Toshihisa Kojima ; Atsushi Kaneko ; Nobuyuki Asai ; Tomonori Kobayakawa ; Naoki IshiguroA review of tocilizumab treatment in 122 rheumatoid arthritis patients included in the Tsurumai Biologics Communication Registry (TBCR) Study.
000669 (2013) Toshihisa Kojima [Japon] ; Yuichiro Yabe ; Atsushi Kaneko ; Yuji Hirano ; Hisato Ishikawa ; Masatoshi Hayashi ; Hiroyuki Miyake ; Hideki Takagi ; Takefumi Kato ; Kenya Terabe ; Tsuyoshi Wanatabe ; Hiroki Tsuchiya ; Daihei Kida ; Tomone Shioura ; Koji Funahashi ; Daizo Kato ; Hiroyuki Matsubara ; Nobunori Takahashi ; Yosuke Hattori ; Nobuyuki Asai ; Naoki IshiguroMonitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis.
000897 (2014) Nobunori Takahashi [Japon] ; Toshihisa Kojima ; Atsushi Kaneko ; Daihei Kida ; Yuji Hirano ; Takayoshi Fujibayashi ; Yuichiro Yabe ; Hideki Takagi ; Takeshi Oguchi ; Hiroyuki Miyake ; Takefumi Kato ; Naoki Fukaya ; Hisato Ishikawa ; Masatoshi Hayashi ; Seiji Tsuboi ; Yasuhide Kanayama ; Daizo Kato ; Koji Funahashi ; Hiroyuki Matsubara ; Yosuke Hattori ; Masahiro Hanabayashi ; Shinya Hirabara ; Kenya Terabe ; Yutaka Yoshioka ; Naoki IshiguroClinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity.
000938 (2014) Takao Koike [Japon] ; Masayoshi Harigai ; Shigeko Inokuma ; Naoki Ishiguro ; Junnosuke Ryu ; Tsutomu Takeuchi ; Syuji Takei ; Yoshiya Tanaka ; Yoko Sano ; Hitomi Yaguramaki ; Hisashi YamanakaEffectiveness and safety of tocilizumab: postmarketing surveillance of 7901 patients with rheumatoid arthritis in Japan.
000B52 (2014) Shinya Hirabara [Japon] ; Nobunori Takahashi ; Naoki Fukaya ; Hiroyuki Miyake ; Yuichiro Yabe ; Atsushi Kaneko ; Takayasu Ito ; Takeshi Oguchi ; Daihei Kida ; Yuji Hirano ; Takayoshi Fujibayashi ; Fumiaki Sugiura ; Masatoshi Hayashi ; Koji Funahashi ; Masahiro Hanabayashi ; Shuji Asai ; Naoki Ishiguro ; Toshihisa KojimaClinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies.
000B75 (2015) Toshihisa Kojima [Japon] ; Yuichiro Yabe [Japon] ; Atsushi Kaneko [Japon] ; Nobunori Takahashi [Japon] ; Koji Funahashi [Japon] ; Daizo Kato [Japon] ; Masahiro Hanabayashi [Japon] ; Shuji Asai [Japon] ; Shinya Hirabara [Japon] ; Nobuyuki Asai [Japon] ; Yuji Hirano [Japon] ; Masatoshi Hayashi [Japon] ; Hiroyuki Miyake [Japon] ; Masayo Kojima [Japon] ; Naoki Ishiguro [Japon]Importance of methotrexate therapy concomitant with tocilizumab treatment in achieving better clinical outcomes for rheumatoid arthritis patients with high disease activity: an observational cohort study.
000C00 (2015) Tomonori Kobayakawa ; Toshihisa Kojima ; Nobunori Takahashi ; Masatoshi Hayashi ; Yuichiro Yabe ; Atsushi Kaneko ; Tomone Shioura ; Kiwamu Saito ; Yuji Hirano ; Yasuhide Kanayama ; Hiroyuki Miyake ; Nobuyuki Asai ; Koji Funahashi ; Shinya Hirabara ; Masahiro Hanabayashi ; Shuji Asai ; Naoki IshiguroDrug retention rates of second biologic agents after switching from tumor necrosis factor inhibitors for rheumatoid arthritis in Japanese patients on low-dose methotrexate or without methotrexate.
000D73 (2015) Atsushi Ogata [Japon] ; Tatsuya Atsumi [Japon] ; Takaaki Fukuda [Japon] ; Yasuhiko Hirabayashi [Japon] ; Masaaki Inaba [Japon] ; Naoki Ishiguro [Japon] ; Motokazu Kai [Japon] ; Daisuke Kawabata [Japon] ; Daihei Kida [Japon] ; Hitoshi Kohsaka [Japon] ; Ryutaro Matsumura [Japon] ; Seiji Minota [Japon] ; Masaya Mukai [Japon] ; Takayuki Sumida [Japon] ; Kiyoshi Takasugi [Japon] ; Shigenori Tamaki [Japon] ; Tsutomu Takeuchi [Japon] ; Atsuhisa Ueda [Japon] ; Kazuhiko Yamamoto [Japon] ; Hisashi Yamanaka [Japon] ; Hajime Yoshifuji [Japon] ; Akira Nomura [Japon]Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis.
001064 (2016) Toshihisa Kojima [Japon] ; Nobunori Takahashi ; Koji Funahashi ; Shuji Asai ; Kenya Terabe ; Atsushi Kaneko [Japon] ; Yuji Hirano [Japon] ; Masatoshi Hayashi [Japon] ; Hiroyuki Miyake [Japon] ; Takeshi Oguchi [Japon] ; Hideki Takagi [Japon] ; Yasuhide Kanayama [Japon] ; Yuichiro Yabe [Japon] ; Tsuyoshi Watanabe [Japon] ; Takayoshi Fujibayashi [Japon] ; Tomone Shioura [Japon] ; Takayasu Ito [Japon] ; Yutaka Yoshioka [Japon] ; Hisato Ishikawa [Japon] ; Nobuyuki Asai ; Toki Takemoto ; Masayo Kojima [Japon] ; Naoki IshiguroImproved safety of biologic therapy for rheumatoid arthritis over the 8-year period since implementation in Japan: long-term results from a multicenter observational cohort study.
001222 (2016) Nobunori Takahashi ; Naoki Ishiguro[Mechanism of action of biological disease--modifying antirheumatic drugs].
001257 (2017) Naoki Ishiguro [Japon] ; Tatsuya Atsumi [Japon] ; Masayoshi Harigai [Japon] ; Tsuneyo Mimori [Japon] ; Norihiro Nishimoto [Japon] ; Takayuki Sumida [Japon] ; Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Ayako Nakasone [Japon] ; Nobuhiro Takagi ; Hisashi Yamanaka [Japon]Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study.
002247 (2019) Shuji Asai [Japon] ; Masatoshi Hayashi [Japon] ; Masahiro Hanabayashi [Japon] ; Yasuhide Kanayama [Japon] ; Toki Takemoto [Japon] ; Yuichiro Yabe [Japon] ; Tomone Shioura [Japon] ; Hisato Ishikawa [Japon] ; Yutaka Yoshioka [Japon] ; Takefumi Kato [Japon] ; Yuji Hirano [Japon] ; Takayoshi Fujibayashi [Japon] ; Yosuke Hattori [Japon] ; Tomonori Kobayakawa [Japon] ; Masahiko Ando [Japon] ; Yachiyo Kuwatsuka [Japon] ; Nobunori Takahashi [Japon] ; Takuya Matsumoto [Japon] ; Nobuyuki Asai [Japon] ; Yasumori Sobue [Japon] ; Tsuyoshi Nishiume [Japon] ; Mochihito Suzuki [Japon] ; Naoki Ishiguro [Japon] ; Toshihisa Kojima [Japon]Discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab: An interventional study.
002697 (2019) Kyosuke Hattori [Japon] ; Yuji Hirano [Japon] ; Yasuhide Kanayama [Japon] ; Nobunori Takahashi [Japon] ; Naoki Ishiguro [Japon] ; Toshihisa Kojima [Japon]Predictors of denosumab efficacy in treating osteoporosis in patients with rheumatoid arthritis: a Japanese multicenter study
002975 (2020) Kyosuke Hattori [Japon] ; Yuji Hirano [Japon] ; Yasuhide Kanayama [Japon] ; Yosuke Hattori [Japon] ; Takefumi Kato [Japon] ; Nobunori Takahashi [Japon] ; Naoki Ishiguro [Japon] ; Toshihisa Kojima [Japon]Efficacy of add-on iguratimod in patients with rheumatoid arthritis who inadequately respond to either tocilizumab or tumor necrosis factor alpha inhibitors.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Naoki Ishiguro" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Naoki Ishiguro" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Naoki Ishiguro
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021